Identification of Compound‐B, a novel anti‐dengue virus agent targeting the non‐structural protein 4A

[1]  R. D. del Ángel,et al.  DENV up-regulates the HMG-CoA reductase activity through the impairment of AMPK phosphorylation: A potential antiviral target , 2017, PLoS pathogens.

[2]  M. Bolognesi,et al.  Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor. , 2016, Antiviral research.

[3]  Nico Stollenwerk,et al.  The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries , 2016, bioRxiv.

[4]  Junchao Cai,et al.  Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS , 2016, Journal of Virology.

[5]  E. Sklan,et al.  Amino Terminal Region of Dengue Virus NS4A Cytosolic Domain Binds to Highly Curved Liposomes , 2015, Viruses.

[6]  David L. Smith,et al.  The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus , 2015, eLife.

[7]  Xuping Xie,et al.  Determinants of Dengue Virus NS4A Protein Oligomerization , 2015, Journal of Virology.

[8]  Kimihito Ito,et al.  Metagenomic analysis of the shrew enteric virome reveals novel viruses related to human stool-associated viruses. , 2015, The Journal of general virology.

[9]  Hongping Dong,et al.  Characterization of Dengue Virus NS4A and NS4B Protein Interaction , 2015, Journal of Virology.

[10]  P. Pitisuttithum,et al.  Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial , 2014, The Lancet.

[11]  Jean Bernatchez,et al.  Dynamics of Hepatitis C Virus (HCV) RNA-dependent RNA Polymerase NS5B in Complex with RNA* , 2014, The Journal of Biological Chemistry.

[12]  Faseeha Noordeen,et al.  Evolution of dengue in Sri Lanka-changes in the virus, vector, and climate. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[13]  Justin Jang Hann Chu,et al.  Cellular Vimentin Regulates Construction of Dengue Virus Replication Complexes through Interaction with NS4A Protein , 2013, Journal of Virology.

[14]  David Beer,et al.  Ten years of dengue drug discovery: progress and prospects. , 2013, Antiviral research.

[15]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[16]  Saravudh Suvannadabba,et al.  Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial , 2012, The Lancet.

[17]  Rosanna W. Peeling,et al.  Dengue: a continuing global threat , 2010, Nature Reviews Microbiology.

[18]  J. Derisi,et al.  Human Enterovirus 109: a Novel Interspecies Recombinant Enterovirus Isolated from a Case of Acute Pediatric Respiratory Illness in Nicaragua , 2010, Journal of Virology.

[19]  Ralf Bartenschlager,et al.  The Non-structural Protein 4A of Dengue Virus Is an Integral Membrane Protein Inducing Membrane Alterations in a 2K-regulated Manner* , 2007, Journal of Biological Chemistry.

[20]  Takayoshi Suzuki,et al.  Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole. , 2006, Bioorganic & medicinal chemistry letters.

[21]  S. Tajima,et al.  Nineteen nucleotides in the variable region of 3' non-translated region are dispensable for the replication of dengue type 1 virus in vitro. , 2006, Virus research.

[22]  S. Harper,et al.  Mechanismof Action and Antiviral Activity of Benzimidazole-Based AllostericInhibitors of the Hepatitis C Virus RNA-Dependent RNAPolymerase , 2003, Journal of Virology.

[23]  Edward C Holmes,et al.  The origin, emergence and evolutionary genetics of dengue virus. , 2003, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[24]  M. Diamond,et al.  Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. , 2002, Virology.

[25]  D. Gubler,et al.  Dengue and dengue haemorrhagic fever , 1998, The Lancet.

[26]  G. Kuno,et al.  Phylogeny of the Genus Flavivirus , 1998, Journal of Virology.

[27]  J Desmyter,et al.  Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. , 1988, Journal of virological methods.

[28]  Y. Kiso,et al.  [Anti-HIV compounds]. , 1993, Nihon rinsho. Japanese journal of clinical medicine.